|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02659 BAO PHARMA-B
Nominal 
() | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (219,781) | (140,213) |
| Net Cash from / (used in) Investing Activities | -- | (122,120) | (136,365) |
| Net Cash from / (used in) Financing Activities | -- | 543,196 | 122,933 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 201,295 | (153,645) |
| Cash & Cash Equivalents at beginning of period | -- | 321,671 | 472,347 |
| Effect of Foreign Exchange Rate Changes | -- | 1,192 | 2,969 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 524,158 | 321,671 |
| Remarks: | Real time quote last updated: 04/12/2025 09:09 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -183,096 |
| %Change | 9.449% |
| EPS / (LPS) | RMB -3.180 |
| NBV Per Share (¥) | RMB -- |